Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
D000315:Adrenalectomy; D000728:Androgens / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D003348:Cortisone / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000728:Androgens; D000970:Antineoplastic Agents; D004967:Estrogens; D013739:Testosterone; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D013852:Thiotepa; D005474:Fluoxymesterone; D005472:Fluorouracil; D003348:Cortisone; D008727:Methotrexate